Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Enviri
NVRI
$624M
| $101K | ﹤0.01% |
16,029
-16,027
| -50% | -$95.5K |
|
|
ESPR
2327
DELISTED
Esperion Therapeutics
ESPR
| $100K | ﹤0.01% |
+16,098
| New | +$115K |
|
2328
Opendoor
OPEN
$3.69B
| $100K | ﹤0.01% |
88,797
-88,814
| -50% | -$170K |
|
2329
Douglas Elliman
DOUG
$155M
| $99.8K | ﹤0.01% |
25,740
-31,523
| -55% | -$126K |
|
|
ACCD
2330
DELISTED
Accolade Inc
ACCD
| $99.8K | ﹤0.01% |
+12,802
| New | +$122K |
|
2331
Allogene Therapeutics
ALLO
$680M
| $99.5K | ﹤0.01% |
15,837
-15,839
| -50% | -$147K |
|
2332
SiriusPoint
SPNT
$2.78B
| $98.3K | ﹤0.01% |
16,650
-16,650
| -50% | -$97.8K |
|
2333
TETRA Technologies
TTI
$1.13B
| $98.3K | ﹤0.01% |
+28,436
| New | +$111K |
|
2334
Smith & Wesson
SWBI
$669M
| $98K | ﹤0.01% |
11,301
-11,301
| -50% | -$119K |
|
2335
Alector
ALEC
$180M
| $97.3K | ﹤0.01% |
10,560
-10,560
| -50% | -$92.1K |
|
2336
Hims & Hers Health
HIMS
$6.26B
| $97.1K | ﹤0.01% |
15,165
-15,169
| -50% | -$86.4K |
|
2337
Lightwave Logic
LWLG
$931M
| $97K | ﹤0.01% |
22,541
-22,545
| -50% | -$160K |
|
2338
Community Health Systems
CYH
$391M
| $97K | ﹤0.01% |
22,485
-22,485
| -50% | -$69.2K |
|
|
WOW
2339
DELISTED
WideOpenWest
WOW
| $96.6K | ﹤0.01% |
10,595
-10,593
| -50% | -$120K |
|
|
EQRX
2340
DELISTED
EQRx, Inc. Common Stock
EQRX
| $95.1K | ﹤0.01% |
38,742
-38,744
| -50% | -$153K |
|
2341
Robinhood
HOOD
$77.7B
| $95K | ﹤0.01% |
11,671
-11,671
| -50% | -$114K |
|
2342
Coherus Oncology
CHRS
$227M
| $94.4K | ﹤0.01% |
11,926
-11,926
| -50% | -$91.8K |
|
|
TWOU
2343
DELISTED
2U Inc
TWOU
| $94.2K | ﹤0.01% |
501
-501
| -50% | -$99.4K |
|
2344
Radiant Logistics
RLGT
$388M
| $92.8K | ﹤0.01% |
+18,227
| New | +$102K |
|
|
ONL
2345
Orion Office REIT
ONL
$148M
| $92.7K | ﹤0.01% |
10,862
-10,862
| -50% | -$99.2K |
|
|
BRY
2346
DELISTED
Berry Corp
BRY
| $92.3K | ﹤0.01% |
11,562
-11,562
| -50% | -$99K |
|
2347
Ezcorp Inc
EZPW
$1.79B
| $90.8K | ﹤0.01% |
+11,124
| New | +$99.2K |
|
|
BRMK
2348
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $90.8K | ﹤0.01% |
25,530
-25,532
| -50% | -$119K |
|
2349
8x8 Inc
EGHT
$262M
| $89.7K | ﹤0.01% |
20,829
-20,829
| -50% | -$83.7K |
|
2350
ARKO Corp
ARKO
$903M
| $89.5K | ﹤0.01% |
10,345
-10,345
| -50% | -$95.8K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.